Short Interest in XORTX Therapeutics Inc. (NASDAQ:XRTX) Increases By 79.0%

XORTX Therapeutics Inc. (NASDAQ:XRTXGet Free Report) saw a significant increase in short interest in April. As of April 30th, there was short interest totaling 79,644 shares, an increase of 79.0% from the April 15th total of 44,502 shares. Approximately 6.1% of the shares of the company are short sold. Based on an average trading volume of 6,498,507 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Read Our Latest Stock Report on XORTX Therapeutics

Institutional Trading of XORTX Therapeutics

A hedge fund recently bought a new stake in XORTX Therapeutics stock. DRW Securities LLC acquired a new position in shares of XORTX Therapeutics Inc. (NASDAQ:XRTXFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 193,599 shares of the technology company’s stock, valued at approximately $109,000. DRW Securities LLC owned approximately 2.78% of XORTX Therapeutics as of its most recent filing with the Securities & Exchange Commission. 0.23% of the stock is currently owned by institutional investors.

XORTX Therapeutics Stock Performance

Shares of XRTX opened at $2.59 on Monday. XORTX Therapeutics has a 12 month low of $1.73 and a 12 month high of $7.05. The stock’s 50 day moving average is $2.32 and its two-hundred day moving average is $2.60. The firm has a market cap of $4.01 million, a P/E ratio of -0.86 and a beta of 0.80.

XORTX Therapeutics (NASDAQ:XRTXGet Free Report) last issued its quarterly earnings results on Thursday, February 26th. The technology company reported ($0.45) earnings per share (EPS) for the quarter.

About XORTX Therapeutics

(Get Free Report)

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.

Recommended Stories

Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.